301 companies
VCXB
10X Capital Venture Acquisition Corp III - Ordinary Shares
10X Capital Venture Acquisition Corp III (NYSE: VCXB) is a special purpose acquisition company sponsored by 10X Capital, focused on identifying high growth businesses domestically and abroad and bringing them to the public markets.
New York
NYSEAMERICAN
FDMT
4D Molecular Therapeutics Inc
the mission of 4d molecular therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions.
California
NASDAQ
AIM
AIM ImmunoTech Inc
aim immunotech inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the united states.
Florida
NYSEAMERICAN
AMGN
AMGEN Inc.
Amgen Inc.
California
NASDAQ
ARIA
ARIAD Pharmaceuticals Inc
ARIAD is a global oncology company focused on transforming the lives of cancer patients with breakthrough medicines.
Massachusetts
NASDAQ
ABCZF
Abcam plc
Abcam is a producer, distributor and seller of protein research tools.
United Kingdom
OTC
XLRN
Acceleron Pharma Inc
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.
Massachusetts
NASDAQ
ACGN
Aceragen Inc
idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases.
Pennsylvania
NASDAQ
ACHL
Achilles Therapeutics Plc
achilles therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.
United Kingdom
NASDAQ
ACORQ
Acorda Therapeutics Inc
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.
New York
NASDAQ
ABOS
Acumen Pharmaceuticals Inc
acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Virginia
NASDAQ
ADAP
Adaptimmune Therapeutics Plc
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer.
United Kingdom
NASDAQ
ADPT
Adaptive Biotechnologies Corp
we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca.
Washington
NASDAQ
ADMA
Adma Biologics Inc
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases.
New Jersey
NASDAQ
APTCF
Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corp.
Massachusetts
OTC
ADVM
Adverum Biotechnologies Inc
adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.
California
NASDAQ
AERI
Aerie Pharmaceuticals Inc
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases.
North Carolina
NASDAQ
GNMX
Aevi Genomic Medicine, LLC
Aevi Genomic Medicine, Inc.
Pennsylvania
NASDAQ
AFTX
Affinia Therapeutics Inc.
Massachusetts
AGTX
Agentix Corp.
AGENTIX is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mellitus, chronic obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). AGENTIX has acquired and is commencing clinical evaluation of certain therapeutic assets exclusively licensed from the National Heath Research Institute Taiwan (NHRI) and Research Triangle Institute (RTI), dba RTI International.
California
OTC